Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTRIAXONE Cause Interstitial lung disease? 78 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Interstitial lung disease have been filed in association with CEFTRIAXONE (Ceftriaxone). This represents 0.4% of all adverse event reports for CEFTRIAXONE.

78
Reports of Interstitial lung disease with CEFTRIAXONE
0.4%
of all CEFTRIAXONE reports
22
Deaths
54
Hospitalizations

How Dangerous Is Interstitial lung disease From CEFTRIAXONE?

Of the 78 reports, 22 (28.2%) resulted in death, 54 (69.2%) required hospitalization, and 21 (26.9%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFTRIAXONE. However, 78 reports have been filed with the FAERS database.

What Other Side Effects Does CEFTRIAXONE Cause?

Off label use (2,201) Drug ineffective (1,862) Condition aggravated (950) Dyspnoea (944) Pyrexia (843) Drug reaction with eosinophilia and systemic symptoms (793) Rash (784) Drug hypersensitivity (760) Acute kidney injury (720) Vomiting (668)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which CEFTRIAXONE Alternatives Have Lower Interstitial lung disease Risk?

CEFTRIAXONE vs CEFTRIAXONE\CEFTRIAXONE CEFTRIAXONE vs CEFUROXIME CEFTRIAXONE vs CEFUROXIME AXETIL CEFTRIAXONE vs CELEBREX CEFTRIAXONE vs CELECOXIB

Related Pages

CEFTRIAXONE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease CEFTRIAXONE Demographics